The life sciences bpo market size has grown strongly in recent years. It will grow from $294.54 billion in 2025 to $323.14 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising operational costs in life sciences companies, increasing complexity of regulatory requirements, early adoption of outsourcing for clinical trials, growth in pharmaceutical and medical device industries, need for specialized expertise.
The life sciences bpo market size is expected to see rapid growth in the next few years. It will grow to $481.84 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing focus on cost efficiency, growing global clinical trial volumes, rising demand for scalable support services, expansion of life sciences companies in emerging markets, higher emphasis on faster product commercialization. Major trends in the forecast period include rising outsourcing of non-core life sciences operations, growing demand for regulatory and compliance support services, increasing adoption of end-to-end bpo solutions, expansion of pharmacovigilance and data management services, rising preference for cost-optimized global delivery models.
The support for clinical trials is expected to drive the growth of the life sciences BPO market in the coming years. Clinical trials support involves the services and activities provided to manage and facilitate clinical trials, which are research studies with human participants aimed at evaluating the safety and efficacy of new drugs, medical treatments, therapies, devices, or interventions. Professionals in clinical trials support ensure the quality and integrity of clinical trial data, making sure it complies with regulatory standards. This focus on data quality is critical for BPO providers handling clinical trial information, often a key service offered to life sciences companies. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the number of pharmaceutical industry trials initiated in the UK rose for the second consecutive year, increasing from 411 in 2022 to 426 in 2023. As a result, clinical trials support is fueling the growth of the life sciences BPO market.
Leading companies in the life sciences BPO market are leveraging strategic partnerships to develop innovative solutions. These partnerships allow life sciences BPO companies to combine resources and expertise, improve research and development capabilities, expand market reach, and accelerate commercialization, ultimately promoting innovation and growth within the industry. For instance, in March 2024, Cognizant Technology Solutions Corp, a US-based company, partnered with NVIDIA, a US-based software firm. Through this collaboration, Cognizant and NVIDIA aim to speed up drug discovery by using NVIDIA's BioNeMo generative AI platform, enabling faster and more efficient analysis of complex datasets. This partnership is designed to enhance research capabilities and accelerate the development of life-saving treatments.
In January 2025, NVIDIA Corporation, a US-based technology company, formed a partnership with IQVIA Holdings Inc. to drive AI-enabled transformation in healthcare and life sciences. Through this collaboration, NVIDIA Corporation and IQVIA Holdings Inc. aim to advance drug discovery, clinical development, and commercial analytics by combining NVIDIA’s AI Foundry services with IQVIA’s comprehensive real-world data resources to deliver faster insights, improve decision-making, and support the creation of innovative therapies. IQVIA Holdings Inc. is a US-based healthcare analytics company that focuses on providing real-world data, AI-driven platforms, and sophisticated analytical solutions for the life sciences sector.
Major companies operating in the life sciences bpo market are Accenture plc, Atos SE, Covance Inc., Genpact Ltd., ICON plc, Infosys Ltd., PAREXEL International Corp., IQVIA Holdings Inc., International Business Machines Corp., Cognizant Technology Solutions, Syneos Health Inc., Charles River Laboratories International Inc., WuXi AppTec Co. Ltd., Medpace Holdings Inc., Pharmaceutical Product Development LLC, Medidata Solutions, Health Decisions Inc., Bioclinica Inc., Navitas Life Sciences Private Limited, SGS SA, PRA Health Sciences Inc., Clinipace Worldwide, ClinTec International Ltd., Cromsource Ltd.
Asia-Pacific was the largest region in the life sciences BPO market in 2025. The regions covered in the life sciences bpo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life sciences bpo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the life sciences bpo market by increasing costs associated with cross-border service delivery, data handling infrastructure, and regulatory support operations. These impacts are more visible in pharmaceutical outsourcing and medical device outsourcing services, particularly in regions such as north america and europe that rely on offshore service providers. Hospitals, clinics, and diagnostic laboratories experience indirect cost pressures due to higher service pricing. On the positive side, tariffs have encouraged regional service hubs, localized outsourcing models, and diversification of service delivery locations, supporting long-term market resilience.
The life sciences bpo market research report is one of a series of new reports that provides life sciences bpo market statistics, including life sciences bpo industry global market size, regional shares, competitors with a life sciences bpo market share, detailed life sciences bpo market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences bpo industry. This life sciences bpo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Life sciences BPO (business process outsourcing) involves providing services that assist life sciences companies in different aspects of their business operations. It entails outsourcing specialized tasks such as data management, regulatory compliance, and customer support related to the life sciences industry to third-party professionals.
The primary types of services offered in life sciences BPO include pharmaceutical outsourcing, medical device outsourcing, contract sales and marketing outsourcing, and others. Pharmaceutical outsourcing involves pharmaceutical companies assigning specific tasks or functions connected to drug development, manufacturing, and distribution to external service providers. These services are applied in areas such as clinical testing methods, environmental testing methods, and more, and are utilized by various end-users, including hospitals, clinics, diagnostic laboratories, and others.
The life sciences BPO market includes revenues earned by entities by providing research and analytics, digital transformation, finance and accounting, and procurement. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The life sciences bpo market size is expected to see rapid growth in the next few years. It will grow to $481.84 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing focus on cost efficiency, growing global clinical trial volumes, rising demand for scalable support services, expansion of life sciences companies in emerging markets, higher emphasis on faster product commercialization. Major trends in the forecast period include rising outsourcing of non-core life sciences operations, growing demand for regulatory and compliance support services, increasing adoption of end-to-end bpo solutions, expansion of pharmacovigilance and data management services, rising preference for cost-optimized global delivery models.
The support for clinical trials is expected to drive the growth of the life sciences BPO market in the coming years. Clinical trials support involves the services and activities provided to manage and facilitate clinical trials, which are research studies with human participants aimed at evaluating the safety and efficacy of new drugs, medical treatments, therapies, devices, or interventions. Professionals in clinical trials support ensure the quality and integrity of clinical trial data, making sure it complies with regulatory standards. This focus on data quality is critical for BPO providers handling clinical trial information, often a key service offered to life sciences companies. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the number of pharmaceutical industry trials initiated in the UK rose for the second consecutive year, increasing from 411 in 2022 to 426 in 2023. As a result, clinical trials support is fueling the growth of the life sciences BPO market.
Leading companies in the life sciences BPO market are leveraging strategic partnerships to develop innovative solutions. These partnerships allow life sciences BPO companies to combine resources and expertise, improve research and development capabilities, expand market reach, and accelerate commercialization, ultimately promoting innovation and growth within the industry. For instance, in March 2024, Cognizant Technology Solutions Corp, a US-based company, partnered with NVIDIA, a US-based software firm. Through this collaboration, Cognizant and NVIDIA aim to speed up drug discovery by using NVIDIA's BioNeMo generative AI platform, enabling faster and more efficient analysis of complex datasets. This partnership is designed to enhance research capabilities and accelerate the development of life-saving treatments.
In January 2025, NVIDIA Corporation, a US-based technology company, formed a partnership with IQVIA Holdings Inc. to drive AI-enabled transformation in healthcare and life sciences. Through this collaboration, NVIDIA Corporation and IQVIA Holdings Inc. aim to advance drug discovery, clinical development, and commercial analytics by combining NVIDIA’s AI Foundry services with IQVIA’s comprehensive real-world data resources to deliver faster insights, improve decision-making, and support the creation of innovative therapies. IQVIA Holdings Inc. is a US-based healthcare analytics company that focuses on providing real-world data, AI-driven platforms, and sophisticated analytical solutions for the life sciences sector.
Major companies operating in the life sciences bpo market are Accenture plc, Atos SE, Covance Inc., Genpact Ltd., ICON plc, Infosys Ltd., PAREXEL International Corp., IQVIA Holdings Inc., International Business Machines Corp., Cognizant Technology Solutions, Syneos Health Inc., Charles River Laboratories International Inc., WuXi AppTec Co. Ltd., Medpace Holdings Inc., Pharmaceutical Product Development LLC, Medidata Solutions, Health Decisions Inc., Bioclinica Inc., Navitas Life Sciences Private Limited, SGS SA, PRA Health Sciences Inc., Clinipace Worldwide, ClinTec International Ltd., Cromsource Ltd.
Asia-Pacific was the largest region in the life sciences BPO market in 2025. The regions covered in the life sciences bpo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life sciences bpo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the life sciences bpo market by increasing costs associated with cross-border service delivery, data handling infrastructure, and regulatory support operations. These impacts are more visible in pharmaceutical outsourcing and medical device outsourcing services, particularly in regions such as north america and europe that rely on offshore service providers. Hospitals, clinics, and diagnostic laboratories experience indirect cost pressures due to higher service pricing. On the positive side, tariffs have encouraged regional service hubs, localized outsourcing models, and diversification of service delivery locations, supporting long-term market resilience.
The life sciences bpo market research report is one of a series of new reports that provides life sciences bpo market statistics, including life sciences bpo industry global market size, regional shares, competitors with a life sciences bpo market share, detailed life sciences bpo market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences bpo industry. This life sciences bpo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Life sciences BPO (business process outsourcing) involves providing services that assist life sciences companies in different aspects of their business operations. It entails outsourcing specialized tasks such as data management, regulatory compliance, and customer support related to the life sciences industry to third-party professionals.
The primary types of services offered in life sciences BPO include pharmaceutical outsourcing, medical device outsourcing, contract sales and marketing outsourcing, and others. Pharmaceutical outsourcing involves pharmaceutical companies assigning specific tasks or functions connected to drug development, manufacturing, and distribution to external service providers. These services are applied in areas such as clinical testing methods, environmental testing methods, and more, and are utilized by various end-users, including hospitals, clinics, diagnostic laboratories, and others.
The life sciences BPO market includes revenues earned by entities by providing research and analytics, digital transformation, finance and accounting, and procurement. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Life Sciences BPO Market Characteristics
3. Life Sciences BPO Market Supply Chain Analysis
4. Global Life Sciences BPO Market Trends and Strategies
5. Life Sciences BPO Market Analysis of End Use Industries
7. Global Life Sciences BPO Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Life Sciences BPO Total Addressable Market (TAM) Analysis for the Market
9. Life Sciences BPO Market Segmentation
10. Life Sciences BPO Market Regional and Country Analysis
11. Asia-Pacific Life Sciences BPO Market
12. China Life Sciences BPO Market
13. India Life Sciences BPO Market
14. Japan Life Sciences BPO Market
15. Australia Life Sciences BPO Market
16. Indonesia Life Sciences BPO Market
17. South Korea Life Sciences BPO Market
18. Taiwan Life Sciences BPO Market
19. South East Asia Life Sciences BPO Market
20. Western Europe Life Sciences BPO Market
21. UK Life Sciences BPO Market
22. Germany Life Sciences BPO Market
23. France Life Sciences BPO Market
24. Italy Life Sciences BPO Market
25. Spain Life Sciences BPO Market
26. Eastern Europe Life Sciences BPO Market
27. Russia Life Sciences BPO Market
28. North America Life Sciences BPO Market
29. USA Life Sciences BPO Market
30. Canada Life Sciences BPO Market
31. South America Life Sciences BPO Market
32. Brazil Life Sciences BPO Market
33. Middle East Life Sciences BPO Market
34. Africa Life Sciences BPO Market
36. Life Sciences BPO Market Competitive Landscape and Company Profiles
37. Life Sciences BPO Market Other Major and Innovative Companies
40. Life Sciences BPO Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Life Sciences BPO Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses life sciences bpo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for life sciences bpo? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The life sciences bpo market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Services: Pharmaceutical Outsourcing; Medical Devices Outsourcing; Contract Sales And Marketing Outsourcing; Other Services2) By Application Area: Clinical Operations; Regulatory And Compliance Operations; Commercial And Market Access Operations; Safety And Pharmacovigilance Operations; Data And Digital Operations
3) By End User: Pharmaceutical Companies; Biotechnology Companies; Medical Device Companies; Contract Research Organizations (CROs); Contract Development And Manufacturing Organizations (CDMOs)
Subsegments:
1) By Pharmaceutical Outsourcing: Drug Development Services; Clinical Trials Management; Regulatory Affairs Services; Pharmacovigilance2) By Medical Devices Outsourcing: Product Development Services; Regulatory Compliance; Quality Assurance And Testing; Supply Chain Management
3) By Contract Sales And Marketing Outsourcing: Sales Force Outsourcing; Marketing Strategy Development; Market Access And Pricing Strategies; Promotional Activities
4) By Other Services: Data Management And Analytics; IT Services; Training And Education; Consulting Services
Companies Mentioned: Accenture plc; Atos SE; Covance Inc.; Genpact Ltd.; ICON plc; Infosys Ltd.; PAREXEL International Corp.; IQVIA Holdings Inc.; International Business Machines Corp.; Cognizant Technology Solutions; Syneos Health Inc.; Charles River Laboratories International Inc.; WuXi AppTec Co. Ltd.; Medpace Holdings Inc.; Pharmaceutical Product Development LLC; Medidata Solutions; Health Decisions Inc.; Bioclinica Inc.; Navitas Life Sciences Private Limited; SGS SA; PRA Health Sciences Inc.; Clinipace Worldwide; ClinTec International Ltd.; Cromsource Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Life Sciences BPO market report include:- Accenture plc
- Atos SE
- Covance Inc.
- Genpact Ltd.
- ICON plc
- Infosys Ltd.
- PAREXEL International Corp.
- IQVIA Holdings Inc.
- International Business Machines Corp.
- Cognizant Technology Solutions
- Syneos Health Inc.
- Charles River Laboratories International Inc.
- WuXi AppTec Co. Ltd.
- Medpace Holdings Inc.
- Pharmaceutical Product Development LLC
- Medidata Solutions
- Health Decisions Inc.
- Bioclinica Inc.
- Navitas Life Sciences Private Limited
- SGS SA
- PRA Health Sciences Inc.
- Clinipace Worldwide
- ClinTec International Ltd.
- Cromsource Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 323.14 Billion |
| Forecasted Market Value ( USD | $ 481.84 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
